Robert S. Fujinami

Professor of Pathology
Neurobiology of Disease
Brain and Behavior
                     
e-mail: robert.fujinami@hsc.utah.edu 
B.A. 1972, University of Utah; Ph.D. 1977, Northwestern University
                     
RESEARCH:
Neuroimmunology/Neurovirology - Understanding immune and viral contributions to the pathogenesis of multiple sclerosis and epilepsy
Virus infection leading to central nervous system (CNS) demyelination.
Theiler's virus causes an encephalomyelitis in mice and this infection mimics multiple
                        sclerosis (MS) in humans. The virus spreads through the CNS and infects white matter
                        particularly the oligodendrocytes and astrocytes. This project involves understanding
                        the virologic and immunologic participation in this CNS demyelinating disease.
                     
How virus infection modulates immune responses leading to autoimmune disease.
Genetically altered viruses encoding myelin proteins can either protect against or
                        enhance an autoimmune disease known as experimental allergic encephalomyelitis (EAE).
                        This is a model for the human disease, MS. These data were generated using viruses
                        encoding myelin basic protein, and myelin proteolipid protein. Other viral constructs
                        coding for other CNS proteins need to be characterized. This project involves definition
                        of how these viral constructs can modulate immune responses and whether infection
                        leads to autoimmune disease.
                     
Virus Infection and Epilepsy.
We have created a new infectious agent model for temporal lobe epilepsy. In our previous
                        studies, SJL/J mice infected with Theiler's murine encephalomyelitis virus (TMEV)
                        develop a persistent viral infection with an inflammatory demyelinating pathology
                        in the CNS. In recent studies, C57BL/6 mice infected with TMEV develop acute seizures
                        that resolve and later have spontaneous seizures. TMEV in C57BL/6 mice targets the
                        hippocampus. The ensuing acute innate inflammatory response contributes to the acute
                        seizures. We are investigating the contributions of the innate immune response to
                        the acquisition of seizures.